# BillionToOne Inc. (BLLN)

Source: https://www.quantisnow.com/company/BLLN
Generated: 2026-11-10T12:32:09.181Z

- Ticker: BLLN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical Specialities
- IPO year: 2025
- SEC CIK: 0002070849

## Latest BLLN news and filings

- 2026-11-09 11:03 UTC [SEC Schedule 13D] [Amendment: SEC Form SCHEDULE 13D/A filed by BillionToOne Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-billiontoone-inc-6779905)
- 2026-11-05 01:42 UTC [SEC Form 4] [SEC Form 4 filed by BillionToOne Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-billiontoone-inc-6773873)
- 2026-11-05 01:42 UTC [SEC Form 4] [SEC Form 4 filed by BillionToOne Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-billiontoone-inc-6773872)
- 2026-11-05 01:42 UTC [SEC Form 4] [Chief Technology Officer Tsao David exercised 20,000 shares at a strike of $2.80 and sold $2,184,854 worth of shares (20,000 units at $109.24) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-technology-officer-tsao-david-exercised-20000-shares-at-a-6773871)
- 2026-11-04 21:47 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by BillionToOne Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-billiontoone-inc-6773339)
- 2026-11-04 21:21 UTC [SEC Form 8-K] [BillionToOne Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/billiontoone-inc-filed-sec-form-8-k-results-of-operations-and-6772954)
- 2026-11-04 21:05 UTC [Earnings] [BillionToOne Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance](https://www.quantisnow.com/insight/billiontoone-reports-third-quarter-2026-results-and-raises-2026-revenue-6772254)
- 2026-10-30 22:54 UTC [SEC Form 4] [Chairman and CEO Atay Oguzhan sold $1,298,000 worth of shares (11,000 units at $118.00) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chairman-and-ceo-atay-oguzhan-sold-1298000-worth-of-shares-6765714)
- 2026-10-30 20:29 UTC [SEC Form 3] [SEC Form 3 filed by BillionToOne Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-billiontoone-inc-6765387)
- 2026-10-27 12:05 UTC [Conference Announcement] [BillionToOne to Participate in Two Upcoming Investor Conferences](https://www.quantisnow.com/insight/billiontoone-to-participate-in-two-upcoming-investor-conferences-6758626)
- 2026-10-19 23:35 UTC [SEC Form 4] [SEC Form 4 filed by BillionToOne Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-billiontoone-inc-6751120)
- 2026-10-16 23:00 UTC [SEC Form 4] [Chairman and CEO Atay Oguzhan sold $1,090,575 worth of shares (11,000 units at $99.14) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chairman-and-ceo-atay-oguzhan-sold-1090575-worth-of-shares-6749669)
- 2026-10-14 22:10 UTC [SEC Form 4] [Chairman and CEO Atay Oguzhan sold $1,823,450 worth of shares (19,334 units at $94.31) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chairman-and-ceo-atay-oguzhan-sold-1823450-worth-of-shares-6746981)
- 2026-10-14 12:05 UTC [Earnings Date] [BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026](https://www.quantisnow.com/insight/billiontoone-to-report-third-quarter-2026-financial-results-on-november-6745972)
- 2026-10-13 22:39 UTC [SEC Form 4] [SEC Form 4 filed by BillionToOne Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-billiontoone-inc-6745572)
- 2026-10-07 23:56 UTC [SEC Form 4] [SVP of Laboratory Operations Ten Bosch John Roderick sold $297,995 worth of shares (2,834 units at $105.15) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/svp-of-laboratory-operations-ten-bosch-john-roderick-sold-297995-6740735)
- 2026-10-07 23:56 UTC [SEC Form 4] [Chief Technology Officer Tsao David sold $2,162,950 worth of shares (20,000 units at $108.15) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-technology-officer-tsao-david-sold-2162950-worth-of-shares-6740733)
- 2026-10-07 11:00 UTC [BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds](https://www.quantisnow.com/insight/billiontoones-tissue-free-northstar-response-demonstrates-on-par-to-superior-cancer-treatment-6739652)
- 2026-10-01 00:33 UTC [SEC Form 4] [Chairman and CEO Atay Oguzhan exercised 8,333 shares at a strike of $2.80 and sold $1,326,919 worth of shares (10,999 units at $120.64) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chairman-and-ceo-atay-oguzhan-exercised-8333-shares-at-a-6731106)
- 2026-09-28 21:57 UTC [SEC Form 4] [Chief Technology Officer Tsao David exercised 3,333 shares at a strike of $2.80 and sold $416,625 worth of shares (3,333 units at $125.00) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-technology-officer-tsao-david-exercised-3333-shares-at-a-6728103)
- 2026-09-28 21:56 UTC [SEC Form 4] [SVP of Laboratory Operations Ten Bosch John Roderick sold $169,920 worth of shares (1,416 units at $120.00) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 22,219 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-of-laboratory-operations-ten-bosch-john-roderick-sold-169920-6728102)
- 2026-09-23 21:50 UTC [SEC Form 4] [SVP of Laboratory Operations Ten Bosch John Roderick sold $150,960 worth of shares (1,416 units at $106.61) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 23,635 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-of-laboratory-operations-ten-bosch-john-roderick-sold-150960-6724508)
- 2026-09-21 23:00 UTC [SEC Form 4] [Officer Lynch Thomas P. exercised 35,112 shares at a strike of $13.61 and sold $3,873,966 worth of shares (35,112 units at $110.33) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/officer-lynch-thomas-p-exercised-35112-shares-at-a-strike-6722144)
- 2026-09-17 20:20 UTC [SEC Form 144] [SEC Form 144 filed by BillionToOne Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-billiontoone-inc-6719265)
- 2026-09-16 22:43 UTC [SEC Form 4] [Chairman and CEO Atay Oguzhan exercised 24,999 shares at a strike of $2.80 and sold $3,030,444 worth of shares (30,331 units at $99.91) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chairman-and-ceo-atay-oguzhan-exercised-24999-shares-at-a-6718082)
- 2026-09-14 22:47 UTC [SEC Form 4] [Chief Product Officer Sakakibara Shan Riku gifted 3,500 shares, decreasing direct ownership by 2% to 196,500 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-product-officer-sakakibara-shan-riku-gifted-3500-shares-decreasing-6715081)
- 2026-09-11 22:01 UTC [SEC Form 4] [SVP of Laboratory Operations Ten Bosch John Roderick sold $138,117 worth of shares (1,416 units at $97.54) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 25,051 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-of-laboratory-operations-ten-bosch-john-roderick-sold-138117-6713384)
- 2026-09-11 22:01 UTC [SEC Form 4] [Chief Technology Officer Tsao David sold $1,975,400 worth of shares (20,000 units at $98.77) as part of a pre-agreed trading plan and exercised 20,000 shares at a strike of $2.80 (SEC Form 4)](https://www.quantisnow.com/insight/chief-technology-officer-tsao-david-sold-1975400-worth-of-shares-6713383)
- 2026-09-10 23:44 UTC [SEC Form 4] [Officer Lynch Thomas P. exercised 20,000 shares at a strike of $13.61 and sold $1,999,880 worth of shares (20,000 units at $99.99) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/officer-lynch-thomas-p-exercised-20000-shares-at-a-strike-6712254)
- 2026-09-10 23:44 UTC [SEC Form 4] [Chairman and CEO Atay Oguzhan converted options into 20,000 shares and gifted 20,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/chairman-and-ceo-atay-oguzhan-converted-options-into-20000-shares-6712252)
- 2026-09-09 01:55 UTC [SEC Form 4] [Chief Technology Officer Tsao David converted options into 20,000 shares and gifted 20,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-technology-officer-tsao-david-converted-options-into-20000-shares-6708956)
- 2026-09-08 17:52 UTC [SEC Form 144] [SEC Form 144 filed by BillionToOne Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-billiontoone-inc-6708076)
- 2026-09-02 20:05 UTC [Conference Announcement] [BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference](https://www.quantisnow.com/insight/billiontoone-to-participate-in-the-wells-fargo-21st-annual-healthcare-6703081)
- 2026-09-02 12:24 UTC [Analyst Coverage Initiated] [Canaccord Genuity initiated coverage on BillionToOne with a new price target](https://www.quantisnow.com/insight/canaccord-genuity-initiated-coverage-on-billiontoone-with-a-new-price-6702454)
- 2026-09-01 13:00 UTC [BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin](https://www.quantisnow.com/insight/billiontoone-launches-northstar-origin-a-new-liquid-biopsy-test-to-6700845)
- 2026-08-28 20:20 UTC [SEC Form 4] [Director Kolluri Krishna Kittu disposed of 484,442 shares and acquired 78,244 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-kolluri-krishna-kittu-disposed-of-484442-shares-and-acquired-6698461)
- 2026-08-28 00:19 UTC [SEC Form 4] [SVP of Laboratory Operations Ten Bosch John Roderick sold $141,700 worth of shares (1,417 units at $100.00) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 26,467 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-of-laboratory-operations-ten-bosch-john-roderick-sold-141700-6697722)
- 2026-08-28 00:19 UTC [SEC Form 4] [Chief Technology Officer Tsao David exercised 10,000 shares at a strike of $2.80 and sold $1,000,000 worth of shares (10,000 units at $100.00) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-technology-officer-tsao-david-exercised-10000-shares-at-a-6697721)
- 2026-08-18 16:08 UTC [Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions](https://www.quantisnow.com/insight/largest-prospective-study-in-general-risk-pregnancies-strengthens-evidence-for-cfdna-6686254)
- 2026-08-12 22:55 UTC [SEC Form 4] [SVP of Laboratory Operations Ten Bosch John Roderick sold $131,583 worth of shares (1,417 units at $92.86) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 27,884 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-of-laboratory-operations-ten-bosch-john-roderick-sold-131583-6678800)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BLLN
- Earnings history: https://www.quantisnow.com/earnings/BLLN
- Dividend history: https://www.quantisnow.com/dividends/BLLN
- Insider transactions: https://www.quantisnow.com/insiders/BLLN
- Options chain: https://www.quantisnow.com/options/BLLN
- SEC 8-K filings only: https://www.quantisnow.com/company/BLLN/8-k
- RSS and alerts for BLLN: https://www.quantisnow.com/docs/rss-feeds.md